Advertisement

Topics

Virbac : operating profit from ordinary activities 2017 comparable to 2016

13:45 EDT 14 Mar 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Virbac: operating profit from ordinary activities 2017 comparable to 2016 Public release dated March 14, 2018 CONSOLIDAT...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Virbac : operating profit from ordinary activities 2017 comparable to 2016"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...